• OPEN AN ACCOUNT
Indian Indices
Sensex
77,566.16 -1,352.74
( -1.71%)
Global Indices
Nasdaq
47,518.20 -457.55
(-0.95%)
Dow Jones
6,761.35 -90.36
(-1.32%)
Hang Seng
52,808.52 -2,812.32
(-5.06%)
Nikkei 225
10,249.54 -35.21
(-0.34%)
Forex
USD-INR
91.74 -0.39
(-0.42%)
EUR-INR
106.47 -0.59
(-0.55%)
GBP-INR
122.42 -0.61
(-0.50%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

kddl ltd
Pfizer announces change in senior management
Jan 20,2026

Pfizer announced the following change in senior management:

  • Nilesh Pendse is appointed as Category Lead – Vaccines of the Company with effect from 01 February 2026. Pendse shall accordingly be a Senior Management Personnel of the Company effective the said date.
  • Manikantan Seshadrinathan – Category Lead, Hospitals & Rare Disease will transition to another role within the Pfizer Group Companies effective 01 February 2026, and shall accordingly cease to be a Senior Management Personnel of the Company effective 31 January 2026.
  • Prashant Mahalingam, Category Lead – Internal Medicine, will take up additional responsibility of the Hospitals Business of the Company and shall be redesignated as Category Lead – Internal Medicine & Hospitals, effective 01 February 2026.